GeneMedi at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

GeneMedi brings 3 presentations to ESGCT 2026 in Hamburg. Its work centres on faster AAV purification and antibody reagents for vector production. One topic is a spin-column affinity system that purifies AAV on a benchtop centrifuge, another is AAV engineered to cross the blood-brain barrier and avoid the liver.

OrganizationESGCT 2026 Attendance
genemedi.net
Tools & reagents
Supplies AAV purification resins and spin columns, titration kits and vector systems, plus AAV, lentiviral and adenoviral packaging and capsid evolution services.
Poster
Wed Oct 28
1:30pm–3:30pm
A rapid，high-throughput AAV purification via a novel affinity spin-column system with benchtop centrifugation
Manufacturing
Poster
Wed Oct 28
1:30pm–3:30pm
Development and application of a novel conformation-specific anti-biotin antibody resistant to free biotin interference
Manufacturing
Poster
Thu Oct 29
2:00pm–4:00pm
Enhanced blood-brain barrier crossing and hepatic detargeting of AAV by displaying anti-TFRC VHH through a versatile separated VP expression platform
AAVs / non integrative vectors

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from GeneMedi

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction